Abstract:Advanced-stage liver metastatic Colorectal Cancer (CRC) disease remission rates are markedly low, often with less time for life-saving but challenging medical procedures and physically demanding regimens of neoadjuvant chemotherapies. Medical decisions supported by patient-specific genomic information may improve cancer prognosis, long-term remission rates, and overall patient health. Understanding the genomic landscape of liver metastasis with respect to primary tumors can help clinical decision-making that may result in added life years for patients with advanced disease. For unresectable metastatic disease, prediction of the possible targetable mutations of both primary colon tumors and liver metastasis could have an impact on treatment decisions and survival rates. In this study 16 samples were collected from five different CRC patients with cooccurring liver metastases. Whole exome sequencing (WES) was performed on an Illumina Hi-Seq 2000. Samples included primary tumor, tumor micro-environment and metastasis (with one patient undergoing a polypectomy). At the biopsy date, treatment naïve samples allowed observation of the natural genomic makeup. Analysis confirmed 70x average coverage. Data were processed with multiple mapping and variant discovery algorithms. In these samples, a putative driver variant, FAM25C was identified, in addition to observing canonic driver mutations for colorectal cancer such as TP53, APC, KRAS. After variant discovery, microsatellite instability and tumor mutation burden (TMB) analyses were conducted. One patient showed high TMB with almost 10-fold more mutations observed, when compared to other samples. All samples of the High-TMB patient share almost half of the same variants, which can be indicative of early expansion of the major clone. Average probabilistic Jaccard similarity coefficient percentages of somatic variants of only primary CRC tumor and liver metastasis tissues were 41.08% with a standard deviation of 4.05% across all patients. Whole exome sequencing of samples with subsequent analysis of clonal variation between CRC tumors and liver metastasis show different mutational composition trends in dissimilarity to the primary tumor. To understand tumor evolution, phylogenetic analysis was conducted for each patient sample. Although different studies were conducted on understanding the genomic properties of metastasis through pairwise comparison, detailed studies which investigate the genomic patterns of tumor expansion through detailed sampling are crucial for effective therapy development. We believe our results in combination with other multi-sample sequencing studies will help the CRC community to better understand this deadly disease, leading to better treatment strategies. These authors hypothesize that investigating clonal diversity via synchronous biopsy in primary and metastatic tumors may be one facet in a larger conversation of treatment decisions and responses of patients who will undergo neoadjuvant chemotherapies for nonresectable liver metastatic CRC disease. Citation Format: Duygu Altinok Dindar, Batuhan Kısakol, Sahin Sarihan, Mehmet Arif Ergun, John Cheney, Emel Ergul, Nihal Uren, Ender Dulundu, Emine Bozkurtlar, Nihat Zafer Utkan, Mehmet Baysan. Investigating primary colorectal cancer tumor and liver metastasis clonality through whole exome sequencing of synchronous biopsies [abstract]. In: Proceedings of the AACR Special Conference on Colorectal Cancer; 2022 Oct 1-4; Portland, OR. Philadelphia (PA): AACR; Cancer Res 2022;82(23 Suppl_1) nr A029.

Abstract 3786: Genomic and transcriptomic characterization of peritoneal, lung and liver metastases of colorectal carcinoma reveals site-specific differences

Abstract 3779: Genomic and clinical characterization of metastatic patterns using real-word data from a large cohort of colorectal cancer patients

Abstract 1160: Investigating spatial gene expression profiling in colorectal cancer: Tumor and stroma comparison between primary lesions and matched liver metastases

Abstract 2759: Transcriptional intra-tumoral heterogeneity of putative therapeutic targets in colorectal cancer peritoneal metastases

Abstract 4382: Genomic Events Associated with Metastasis of Colorectal Cancer by Whole-Genome Sequencing

Abstract A029: Investigating primary colorectal cancer tumor and liver metastasis clonality through whole exome sequencing of synchronous biopsies

Abstract 1272: Spatial profiling of human colorectal cancer brain metastasis identifies chromosomal instability with adaptive niche cellular reorganization and reprograming

Abstract 2741: Comprehensive Molecular Profiling of Primary Tumors and Paired Distant Metastases in Non-Small Cell Lung Cancer

Abstract 4978: Genomic characterization of metastatic pancreatic cancer according to tumor sample sites

Abstract 5052: Novel drug resistance mechanisms and drug targets in BRAF mutated peritoneal metastasis from colorectal cancer

Abstract 2523: Novel genomic characterization in late stage colorectal cancer

Abstract 3056: Gut microbial co-metabolism influences the tumor microenvironment

Abstract 2711: Whole Exome Sequencing Analyses of Colorectal Cancers Associated with Liver Metastasis

Genomic Characterization of Metastatic Lung Cancers.

Abstract 2750: Leveraging machine-learning approaches to dissect drivers of clinical metastatic dynamics in lung adenocarcinoma

Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer

Genetic characteristics of isolated lung metastasis and isolated liver metastasis from colorectal cancer

Abstract 4979: Genomic profiling of early-onset metastatic colorectal cancer based on tumor sample location

Molecular Differences between Hepatic and Extrahepatic Metastases from Left-Sided and Right-Sided Colorectal Cancer: Potential Metastatic and Prognostic Biomarkers

Abstract 6806: Single cell RNA sequencing of human and murine cancers demonstrates metastases-specific neutrophil phenotypes driven by the IL-1β/CXCR2 signaling axis - Disruption of this pathway abrogates neutrophil immunosuppressive effects and reduces tumor burden

Abstract 1153: Using spatial transcriptomics to dissect cell to cell cooperation in lung adenocarcinoma